Conference Dates: December 17–19, 2025
Venue: Novotel Al Barsha, Dubai, UAE
Know More: https://pharmacy.utilitarianconferences.com/speaker/dr-hafsa-shafique
The 17th Global Digital Pharma, Clinical Trials and Drug Delivery Conference proudly welcomes Dr. Hafsa Shafique, a rising expert in hepatology research, as a distinguished speaker. Her presentation, titled “Exploring the Therapeutic Effects of Vitamin E on Liver Fibrosis Progression: A Comprehensive Study of Stiffness and Fibrosis Stages,” provides new hope for improving the management of liver diseases worldwide.
Join us at our conference to discover cutting-edge research, global networking, and world-class scientific discussions.
📞 WhatsApp:
https://wa.me/+971551792927
Liver fibrosis is a major global health challenge with serious implications if left unmanaged. Exploring therapeutic strategies that slow or reverse fibrosis progression is critical.
Dr. Hafsa Shafique’s research brings forward valuable insights into the role of Vitamin E in reducing liver stiffness and improving fibrosis stages. At the Dubai conference, she will share a comprehensive overview of her findings, offering clinicians, researchers, and pharma professionals a fresh perspective on hepatology innovations.
Her participation reinforces the conference's mission to highlight transformative developments in digital pharma, clinical research, and therapeutic science.
By attending Dr. Hafsa Shafique’s session—and the conference in general—participants gain:
✔ Exclusive Access to Breakthrough Hepatology Research
Dive deep into Vitamin E’s therapeutic potential in liver fibrosis management.
✔ Latest Knowledge in Liver Stiffness Assessment
Explore innovative tools for staging and evaluating liver fibrosis.
✔ Global Networking Opportunities
Connect with scientists, pharma executives, digital health leaders, and medical experts.
✔ Professional Skill Enhancement
Stay ahead with updates on drug development, clinical trials, and healthcare technology.
Accredited participation helps enhance your scientific and clinical credentials.
Join us at our conference — Register Now:
🔗 https://pharmacy.utilitarianconferences.com/registration
🔗 https://pharmacy.utilitarianconferences.com/accreditation-registration
Dr. Hafsa Shafique’s key research areas include:
- Liver Fibrosis & Cirrhosis
- Hepatology & Gastroenterology
- NAFLD/NASH Progression
- Vitamin E & Antioxidant Therapies
- Non-invasive Liver Stiffness Tools
- Clinical Trial Approaches for Liver Disorders
Her dedication positions her as a strong voice in advancing global liver disease research.
Awards, Recognition & Achievements
Dr. Hafsa Shafique has been honored with:
- Excellence Awards in Hepatology Research
- Innovation Recognition in Liver Disease Studies
- Publications in Renowned Medical Journals
- Invitations to International Medical Conferences
- Contributions to Antioxidant-based Liver Therapy Research
Her achievements reflect her commitment to improving hepatology outcomes.
Conclusion
Dr. Hafsa Shafique’s presentation at the 17th Global Digital Pharma, Clinical Trials and Drug Delivery Conference is set to be one of the event’s highlights. Her compelling research on Vitamin E’s role in liver fibrosis progression offers promising therapeutic insights.
Join us at our conference to learn, collaborate, and explore the future of hepatology, pharma innovation, and clinical science.
Secure your seat today:
🔗 https://pharmacy.utilitarianconferences.com/registration
Hashtags: